On the Edge of a Digital Pathology Transformation: Views from a Cellular Pathology Laboratory Focus Group
- PMID: 31897354
- PMCID: PMC6909548
- DOI: 10.4103/jpi.jpi_38_19
On the Edge of a Digital Pathology Transformation: Views from a Cellular Pathology Laboratory Focus Group
Abstract
Introduction: Digital pathology has the potential to revolutionize the way clinical diagnoses are made while improving safety and quality. With a few notable exceptions in the UK, few National Health Service (NHS) departments have deployed digital pathology platforms. Thus, in the next few years, many departments are anticipated to undergo the transition to digital pathology. In this period of transition, capturing attitudes and experiences can elucidate issues to be addressed and foster collaboration between NHS Trusts. This study aims to qualitatively ascertain the benefits and challenges of transitioning to digital pathology from the perspectives of pathologists and biomedical scientists in a department about to undergo the transition from diagnostic reporting via traditional microscopy to digital pathology.
Methods: A focus group discussion was held in the setting of a large NHS teaching hospital's cellular pathology department which was on the brink of transitioning to digital pathology. A set of open questions were developed and posed to a group of pathologists and biomedical scientists in a focus group setting. Notes of the discussion were made along with an audio recording with permission. The discussion was subsequently turned into a series of topic headings and analyzed using content analysis.
Results: Identified benefits of digital pathology included enhanced collaboration, teaching, cost savings, research, growth of specialty, multidisciplinary teams, and patient-centered care. Barriers to transitioning to digital pathology included standardization, validation, national implementation, storage and backups, training, logistical implementation, cost-effectiveness, privacy, and legality.
Conclusion: Many benefits of digital pathology were identified, but key barriers need to be addressed in order to fully implement digital pathology on a trust and national level.
Keywords: Artificial intelligence; computational pathology; digital pathology; image analysis; whole-slide imaging.
Copyright: © 2019 Journal of Pathology Informatics.
Conflict of interest statement
There are no conflicts of interest.
References
-
- Williams BJ, Bottoms D, Treanor D. Future-proofing pathology: The case for clinical adoption of digital pathology. J Clin Pathol. 2017;70:1010–8. - PubMed
-
- Griffin J, Treanor D. Digital pathology in clinical use: Where are we now and what is holding us back? Histopathology. 2017;70:134–45. - PubMed
-
- Bell J. Life Sciences Industrial Strategy. 2017. [Last accessed on 2019 Mar 14]. Available from: https://assets.publishing.service.gov.uk/government/uploads/system/uploa... .
-
- Cancer Research UK. Testing Times to Come? An Evaluation of Pathology Capacity across the UK. 2016
-
- Stratman C, Drogowski L, Ho J. Digital pathology in the clinical workflow: A time and motion study. Pathol Vis San Diego Calif Digit Pathol Assoc. 2011
